Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in macrophages correlates with tumor angiogenesis and prognosis in invasive breast cancer

International Journal of Oncology

Volumn 13, Issue 3, 1998, Pages 449-454

  Nagaoka, Hiroshi ^a   Iino, Yuichi ^a   Takei, Hiroyuki ^a   Morishita, Yasuo ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Breast cancer; Immunohistochemistry; Macrophage; Platelet derived endothelial cell growth factor thymidine phosphorylase; Prognosis

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; FLUOROURACIL; MITOMYCIN C; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; PREDNISOLONE; TAMOXIFEN; THYMIDINE PHOSPHORYLASE;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MAJOR CLINICAL STUDY; MASTECTOMY; PRIORITY JOURNAL; STROMA CELL; TUMOR VASCULARIZATION;

EID: 0031876708     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.3.449     Document Type: Article

References (41)

1. Folkman J and Shing Y: Angiogenesis. J Biol Chem 267: 10931-10934, 1992.
2. Blood CH and Zetter BR: Tumor interactions with the vasculature: angiogenesis and tumor metastasis. Biochim Biophys Acta 1032: 89-118, 1990.
3. Klagsbrun M and D'Amore PA: Regulators of angiogenesis. Annu Rev Physiol 53: 217-239, 1991.
4. Weidner N, Semple JP, Welch WR and Folkman J: Angiogenesis and metastasis: correlation in invasive breast carcinoma. N Engl J Med 324: 1-8, 1991.
5. Horak ER, Leek R, Klenk N, LeJeune S, Smith K, Stuart N, Greenall M, Stepiewska K and Harris AL: Angiogenesis associated by platalet/endothelial cell adhesion molecule antibodies, as indicator of node metastasis and survival in breast cancer. Lancet 340: 1120-1124, 1992.
6. Bosari S, Lee AK, DeLellis RA, Wiley BD, Heatley GJ and Silverman ML: Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol 23: 755-761, 1992.
7. Folkman J: What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82: 4-6, 1990.
8. Bicknell R and Harris AL: Novel growth regulatory factors and tumor angiogenesis. Eur J Cancer 27: 781-784, 1991.
9. Leung DW, Cachianes G, Kuang WJ, Goeddel D and Ferrara N: Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989.
10. Schulze-Osthoff K, Fruhbeis B, Overwien B, Hilbig B and Sorg C: Purification and characterization of a novel human angiogenic factor (h-AF). Biochem Biophys Res Commun 146: 945-952, 1987.
11. Van Hinsbergh VWM, Kooistra T, Emeris JJ and Koolwijk P: Regulation of plasminogen activator production by endothelial role in fibrinolysis and local proteolysis. Int J Radiol 60: 261-272, 1991.
12. Hockel M, Sasse J and Wissler JH: Purified monocyte-derived angiogenic substance (angiotropin) stimulates migration, phenotyping changes, and tube formation but not proliferation of capillary endothelial cells in vivo. J Cell Physiol 133: 1-13, 1987.
13. Haraguchi M, Miyadera K and Sumizawa T: Angiogenic activity of thymidine phosphorylase and PD-ECGF. Proc Am Assoc Cancer Res 53: 5680-5682, 1993.
14. Toi M, Hoshina S, Taniguchi T, Yamamoto Y, Ishituka H and Tominaga T: Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer. Int J Cancer 64: 79-82, 1995.
15. Moghaddam A, Zhang HT, Fan TPD, Hu DE, Lee VC, Turley H, Fox SB, Gatter KC, Harris AL and Bicknell R: Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci USA 92: 998-1002, 1995.
16. Finnis C, Dodsworth N, Pollitt CE, Carr G and Sleep D: Thymidine phoshorylase activity of platelet derived endothelial cell growth factor is responsible for endothelial cell mitogenicity. Eur J Biochem 212: 201-210, 1993.
17. Ishikawa F, Miyazono K, Hellman U, Drexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risaau W and Heldin CH: Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 338: 557-562, 1989.
18. Takahashi H, Uchino J, Ogita M, Sasaki F, Hata Y, Yoshimoto M, Akasaka Y, Nakanishi Y and Sawada Y: Pyrimidine nucleoside phoshorylase activity and biological characteristics of breast cancer. Int J Oncol 7: 1139-1144, 1995.
19. Usuki K, Saras J, Waltenberger J, Miyazono K, Pierce G, Thomason A and Heldin CH: Platelet-derived endothelial cell growth factor has thymidine phosphorylase activity. Biochem Biophys Res Commun 184: 1311-1316, 1992.
20. Patterson AV, Zhang H, Moghaddam A, Bicknell R, Talbot DC, Stratford IJ and Harris AL: Increased sensitivity to the prodrug 5'-deoxy-5-fluorouridine and modulation of 5-fluoro-2'-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase. Br J Cancer 72: 669-675, 1995.
21. Fox SB, Westwood M, Moghaddam A, Comley M, Turley H, Whitehouse RM, Bicknell R, Gatter KC and Harris AL: The angiogenic factor platelet-derived endothelial cell growth factor/ thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium. Br J Cancer 73: 275-280, 1996.
22. Mitutani Y, Okada Y and Yoshida O: Expression of platelet-derived endothelial cell growth factor in bladder carcinoma. Cancer 79: 1190-1194, 1997.
23. Giatromanoraki A, Koukourakis MI, Comley M, Kaklamanis L, Turley H, O'Byrne KJ, Harris AL and Gatter AK: Platelet-derived endothelial cell growth factor (thymidine phosphorylase) expression in lung cancer. J Pathol 181: 196-199, 1997.
24. Koukourakis MI, Giatromanolaki A, O'Byrne KJ, Comley M, Whitehouse RM, Talbot DC, Gatter KC and Harris AL: Platelet-derived endothelial cell growth factor expression correlates with tumor ansiogenesis and prognosis in non-small-cell lung cancer. Br J Cancer 75: 477-481, 1997.
25. Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T, Yamada Y, Murata F and Aikou T: Clinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 88: 1110-1117, 1996.
26. Takebayashi Y, Miyadera K, Akiyama S, Hokita S, Yamada K, Akiba S, Yamada Y, Sumizawa T and Aikou T: Expression of thymidine phosphorylase in human gastric carcinoma. Jpn J Cancer Res 87: 288-295, 1996.
27. International Union Against Cancer: TNM Atlas, Illustrated Guide to the TNM/pTNM Classification of Malignant Tumours. 3rd edition. Springer-Verlag, Berlin, pp174-183, 1989.
28. World Health Organization: Histological typing of breast tumours. International Histological Classification of tumours No. 2. 2nd edition. World Health Organization, Geneva, pp15-25, 1981.
29. 125I-estradiol-17 β. Prog Med 3: 339-404, 1983.
30. Martinez PL, Platt N, McKnight AJ, DaSilva RP and Gordon S: Macrophage membrane molecules: markers of tissue differentiation and heterogeneity. Immunobiology 195: 407-416, 1996.
31. Takei H, lino Y, Horiguchi J, Maemura M, Koibuchi Y, Nagaoka H, Yokoe T, Oyama T and Morishita Y: Angiogenesis and stromal fibronectin expression in invasive breast carcinoma. Int J Oncol 12: 517-523, 1998.
32. Haraguchi M, Miyadera K, Uemura K, Sumizawa T, Furukawa T, Yamada K and Akiyama S: Angiogenic activity of enzymes. Nature 368: 198, 1994.
33. Fox SB, Moghaddam A, Westwood M, Turley H, Bicknell R, Gatter KC and Harris AL: Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissue: an immonohistochemical study. J Pathol 176: 183-190, 1995.
34. Takahashi Y, Bucana CD, Liu W, Yoneda J, Kitadai Y, Cleary KR and Ellis LM: Platelet-derived endothelial cell growth factor in human colon cancer angiogenesis: role of infiltrating cells. J Natl Cancer Inst 88: 1146-1151, 1996.
35. Leibovich SJ, Polverivi PJ, Shepard HM, Wiseman DM, Shively V and Nuseir N: Macrophage-induced angiogenesis is mediated by tumor necrosis factor-alpha. Nature 329: 630-632, 1987.
36. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R and Sorg C: Macrophages and angiogenesis. J Leukoc Biol 55: 410-422, 1994.
37. Besner GE and Klagsbrun M: Macrophage secrete a heparine-binding inhibitir of endothelial cell growth. Microvasc Res 42: 187-197, 1991.
38. Leek RD, Lewis CE, Whitehouse R, Greenall M, Clarke J and Harris AL: Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 56: 4625-4629, 1996.
39. Polverini PJ and Leibovich SJ: Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest 51: 635-642, 1984.
40. Eda H, Fujimoto K, Watanabe S, Ura M, Hino A, Tanaka Y, Wada K and Ishituka H: Cytokine induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5'-deoxy-5-fluorouridine. Cancer Chemother Pharmacol 32: 333-338, 1993.
41. Griffiths L and Stratford IJ: Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy. Br J Cancer 76: 689-693, 1997.